Justin J. Leitenberger, M.D.

  • Associate Professor of Dermatology, School of Medicine

Biography

Dr. Leitenberger is an Associate Professor of Dermatology and Surgery and the Co-Director of Dermatologic Surgery. Dr. Leitenberger specializes in skin cancer surgery, including Mohs micrographic surgery and subsequent reconstruction.  He has advanced training in laser and cosmetic surgery, including laser skin resurfacing, scar revision, and injectable fillers and neurotoxins. Dr. Leitenberger is board-certified in both Dermatology and Mohs micrographic surgery.

He also serves as Associate Program Director for the ACGME-accredited Mohs Micrographic Surgery and Dermatologic Oncology Fellowship, where he teaches and supervises surgical fellows and residents in skin cancer treatments and advanced reconstruction.

Dr. Leitenberger received his medical degree from the University of Texas McGovern Medical School at Houston, during which time he received the Doris Duke Clinical Research Fellowship Award at the University of Texas Southwestern Medical Center at Dallas. He completed both his dermatology residency and surgical fellowship subspecialty training at OHSU.

Dr. Leitenberger has published over 80 peer-reviewed original articles, book chapters, and abstracts on the Mohs technique for melanoma, complex reconstruction, and prevention of complications after Mohs micrographic surgery.  He has given over 70 national and international presentations and is regularly invited to speak at the American College of Mohs Surgery, the American Society for Dermatologic Surgery, and the American Academy of Dermatology.  He is the current president of the International Transplant Skin Cancer Collaborative

Outside of work, Dr. Leitenberger enjoys spending time with his wife and two boys exploring the beauty of the Northwest.  He enjoys running, cycling, and kitesurfing.

Education and training

  • Degrees

    • B.S., 2003, University of Notre Dame
    • M.D., 2008, University of Texas McGovern Medical School at Houston
  • Residency

    • Dermatology, Oregon Health & Science University, Portland, OR
  • Fellowship

    • Dermatologic surgery, Oregon Health & Science University, Portland, OR
  • Certifications

    • American Board of Dermatology, Dermatology
    • American Board of Dermatology, Mohs micrographic surgery

Memberships and associations:

  • American Academy of Dermatology
  • American Society for Dermatologic Surgery
  • Dermatology Foundation
  • American College of Mohs Surgery
  • Oregon Medical Association
  • Oregon Dermatology Society

Publications

Elsevier pure profile

Selected publications

  • Tumor-initiating cells establish an IL-33-TGF-β niche signaling loop to promote cancer progression. Taniguchi S, Elhance A, Van Duzer A, Kumar S, Leitenberger JJ, Oshimori N. Science. 2020 Jul 17;369(6501):eaay1813. doi: 10.1126/science.aay1813. PMID: 32675345.
  • Defining recurrence of nonmelanoma skin cancer after Mohs micrographic surgery: Report of the American College of Mohs Surgery Registry and Outcomes Committee. Leitenberger JJ, Rogers H, Chapman JC, Maher IA, Fox MC, Harmon CB, Bailey EC, Odland P, Wysong A, Johnson T, Wisco OJ. J Am Acad Dermatol. 2016 Nov;75(5):1022-1031. doi: 10.1016/j.jaad.2016.06.047. Epub 2016 Aug 18. PMID: 27546292.
  • Recommendations for Solid Organ Transplantation for Transplant Candidates With a Pretransplant Diagnosis of Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma and Melanoma: A Consensus Opinion From the International Transplant Skin Cancer Collaborative (ITSCC). Zwald F, Leitenberger J, et al. Am J Transplant. 2016 Feb;16(2):407-13. doi: 10.1111/ajt.13593.
  • Invasive Melanoma and Melanoma in Situ Treated With Modified Mohs Micrographic Surgery With En Face Permanent Sectioning: A 10-Year Retrospective Review. Heath M, Woody M, Leitenberger J, Latour E, Bar A. Dermatol Surg. 2020 Aug;46(8):1004-1013. doi: 10.1097/DSS.0000000000002246. PMID: 31714384.
  • Identifying and defining complications of dermatologic surgery to be tracked in the American College of Mohs Surgery (ACMS) Registry. Council ML, Alam M, Gloster HM Jr, Bordeaux JS, Carroll BT, Leitenberger JJ, Wisco OJ, Maher IA. J Am Acad Dermatol. 2016 Apr;74(4):739-45. doi: 10.1016/j.jaad.2015.10.023. Epub 2015 Nov 24. PMID: 26621700.
  • Opioid Prescribing Recommendations After Mohs Micrographic Surgery and Reconstruction: A Delphi Consensus. Donigan JM, Srivastava D, Maher I, Abdelmalek M, Bar AA, Blalock TW, Bordeaux JS, Brodland DG, Carroll BT, Council ML, Duffy K, Fathi R, Golda N, Johnson-Jahangir H, Konda S, Leitenberger JJ, et al.  Dermatol Surg. 2020 Aug 3. doi: 10.1097/DSS.0000000000002551.
  • Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States. Garrett GL, Blanc PD, Boscardin J, Lloyd AA, Ahmed RL, Anthony T, Bibee K, Breithaupt A, Cannon J, Chen A, Cheng JY, Chiesa-Fuxench Z, Colegio OR, Curiel-Lewandrowski C, Del Guzzo CA, Disse M, Dowd M, Eilers R Jr, Ortiz AE, Morris C, Golden SK, Graves MS, Leitenberger JJ et al.
  • Aggressive Skin Cancers Occurring in Patients Treated With the Janus Kinase Inhibitor Ruxolitinib. Blechman AB, Cabell CE, Weinberger CH, Duckworth A, Leitenberger JJ, Zwald FO, Russell MA. J Drugs Dermatol. 2017 May 1;16(5):508-511. PMID: 28628689.
  • Reconstruction After Full-Thickness Loss of the Antihelix, Scapha, and Triangular Fossa. Leitenberger JJ, Golden SK. Dermatol Surg. 2016 Jul;42(7):893-6. doi: 10.1097/DSS.0000000000000664. PMID: 26885837.
  • Sebaceous carcinoma: evidence-based clinical practice guidelines. Owen JL, Kibbi N, Worley B, Kelm RC, Wang JV, Barker CA, Behshad R, Bichakjian CK, Bolotin D, Bordeaux JS, Bradshaw SH, Cartee TV, Chandra S, Cho NL, Choi JN, Council ML, Demirci H, Eisen DB, Esmaeli B, Golda N, Huang CC, Ibrahim SF, Leitenberger JJ, et al. Lancet Oncol. 2019 Dec;20(12):e699-e714. doi: 10.1016/S1470-2045(19)30673-4. PMID: 3

Publications